文章
醫療新知 > Coca-Cola May Soon Be Used In Cancer Medication?

Coca-Cola May Soon Be Used In Cancer Medication?

19-03-2016

 曾否幻想過汽水, 糖果, 零食能夠治療疾病



根據德國Erasmus MC 癌症臨床研究中心發表,酸性飲料有助於提供肺癌標靶藥物Tarceva在胃裡的理想環境,提升藥物的療效。
由於肺癌標靶藥物Tarceva的有效性及吸收與胃中的酸鹼度PH值相關,而常與Tarceva一起服用的質子幫浦抑制劑(PPI),會大量提升胃中的PH值成強鹼度,將影響標靶藥物的吸收達61%
研究中,肺癌病患在服用標靶藥物及PPI藥物(Nexium)時,同時喝可口可樂時,Tarceva的吸收率大量的提升,也讓治療效果更好。
研究醫師說,可口可樂是一種強酸的飲料,病患一次服用250ml是可容許的範圍


吃標靶藥配可口可樂,會變成標配嗎?!!

(鳴謝 : 台灣全癌症病友連線  )

 

—————————————————————————————————


Coca-Cola
 may play an important role in the absorption of a lung cancer medication, as claimed by some scientists from Erasmus MC Cancer Institute in Rotterdam, the Netherlands.

Coca-Cola Classic, to be precise, is being seen as the acidic beverage that could help create the ideal environment in the stomach for the lung cancer drug Tarceva (erlotinib) to be more effectively absorbed.

According to the Dutch scientists, the absorption and effectiveness of Tarceva is reliant on the pH levels in the stomach. However, certain proton pump inhibitors (PPIs) that are prescribed with the cancer drug tend to raise the pH in the stomach to high alkalinity.

The raised alkalinity lowers the absorption of Tarceva by almost 61% eventually cutting down its effectiveness.

 

Coca-Cola used to increase acidity

Researcher  Dr. Roelof van Leeuwen, says that he wondered if the pH could be reversed and environment in stomach made more conducive by taking Tarceva with the cola beverage as the latter is acidic.

As part of his study, he observed the effect of the combination on 28 volunteers and found that the patients taking Nexium (a PPI) with Tarceva when administered the dose along with Coca-Cola Classic in a set order, could absorb the medication better.

“Cola intake led to a clinically relevant and statistically significant increase” in Tarceva absorption, said the research team in the online Journal of Clinical Oncology.

The researchers are of the opinion that drinking half-a-can of Cola while taking Tarceva could improve the effectiveness of the medication.

“Unfortunately, many patients requiring Tarceva also need proton pump inhibitors to decrease stomach acidity caused by gastritis” — an irritation of the stomach lining — or by the drugs they are taking, such as certain painkillers, said Dr. Alan Mensch of Northwell Health’s Plainview Hospital, in Plainview, N.Y.

“The result is less stomach acid and less absorption of Tarceva, making the drug less effective in treating the cancer,” he explained.

The scientists explained that Coca-Cola was a choice because it was the most acidic of the beverages. Besides, the patients too felt that 250 ml of the beverage was well-tolerated.

The research may open up new arenas of effectiveness of cancer drugs in other cancers as well.

Read more: http://www.healthaim.com/coca-cola-may-soon-used-cancer-medication/40647#ixzz43Ivwtku9

疑難排解

會員註冊


或許你會想看
【跨境醫療】「醫健通」新增三間可授權指定境外醫療機構存入放射檢查報告
由一月二十七日起,香港市民可透過「醫健通」流動應用程式的「個人資料夾」功能,授權指定境外醫療機構,為他們上載放 […]
【乳癌治療日新月異】助你繼續綻放健康美麗 趙頴欣醫生 內腫瘤科專科醫生
乳癌是本港的頭號婦女癌症,近年確診個案更時有增無減。隨著醫學技術進步,癌症治療的選擇愈來愈多,療效也不斷提升及 […]
兒童癌病康復者的長期護理需要
醫療技術進步和癌症治療突破,使兒童癌症的存活率提高。然而,癌症及其治療對兒童的身心健康產生長期不良影響,因此為 […]
【公營醫療】全年收費上限申請
如市民在公營醫療年度費用(每年1月1日至12月31日)超過「全年收費上限」 HKD10000, 謹記通過醫管局 […]
【港大研究】港大醫學院研究證實前列腺癌篩查極具成本效益 有效降低晚期前列腺癌比例及死亡率
港大醫學院研究證實前列腺癌篩查極具成本效益 有效降低晚期前列腺癌比例及死亡率 倡本港廣泛推行 香港大學李嘉誠醫 […]
【港大醫學院】破解胃癌「代謝密碼」 胃癌腫瘤生長減緩達65% 神經元滲透性胃癌配合膽固醇抑制劑 殺死癌細胞效果提高6.3倍
香港大學李嘉誠醫學院(港大醫學院)的研究團隊在胃癌研究上取得突破,揭示人體「第二大腦」——消化系統中的腸神經元 […]
中大臨床研究利用球囊心包切開術治療心包積水 術後復發率大減8成 患者免受重複入院「拮針」引流之苦
每五名癌症患者就有一人出現惡性心包積水,傳統心包穿刺引流術雖可減少心包填塞的風險,惟復發的機會高達60%。香港 […]
香港科大工学院研发AI病理系统SmartPath 提供一站式癌症诊断支援
香港科技大学(科大)成功研发创新人工智能(AI)系统SmartPath,革新癌症病理诊疗全流程。系统由科大计算 […]
【人工智能】BioMap 開展新的聯合研究合作計劃
在剛結束的「第二屆國際生物計算創新峰會」上香港遺傳性乳癌家族資料庫  HK Hereditary Breast […]
【香港乳癌基金會】第12屆周年乳癌科學會議2025 「乳癌年度新發展 – 從研究到臨床應用」 借鏡其他亞洲地區 推動全民乳癌篩查
【香港,2025 年 11 月 9 日】乳癌自1994年起成為本港女性的頭號癌症,每日平均有約15人確診乳癌。 […]
【跨境醫療】保誠與IHH醫療集團(北亞洲)深化合作 進一步拓展香港及中國內地醫療費用直付服務網絡
(香港,2025年11月10日)保誠保險有限公司 (「保誠」)今日宣佈,繼早前與 IHH醫療集團 (北亞洲)旗 […]
【HKNOS2025】探討復發性腦瘤治療的最新進展
非常榮幸出席HKNOS2025 年度科學會議,與各地專家交流分享 ,探討復發性腦瘤治療的最新進展」。 這為我們 […]